A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly's Q1 [Forbes]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Forbes
(NYSE: LLY) will report its Q1 results on Tuesday, April 30. The pharmaceutical giant is expected to garner $8.9 billion in sales and $2.46 in adjusted earnings per share, per the consensus estimates. All eyes will be on Eli Lilly's diabetes drug – Mounjaro – and its weight-loss drug – Zepbound. In this note, we discuss some of the trends that are likely to drive Eli Lilly's results. Firstly, let us look at its stock performance. Eli Lilly has been a great wealth creator in recent years, with its stock seeing stellar gains of 330% from levels of $170 in early January 2021 to around $730 now. This compares with an increase of about 35% for the S&P 500 over this roughly three-year period. Admirably, LLY stock has outperformed the broader market in each of the last three years. Returns for the stock were 64% in 2021, 32% in 2022, and 59% in 2023. In comparison, returns for the S&P 500 have been 27% in 2021, -19% in 2022, and 24% in 2023. In fact, consistently beating the S&P 500 — i
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Why Eli Lilly Stock Jumped by 4% Today [Yahoo! Finance]Yahoo! Finance
- Lilly Declares Second-Quarter 2024 DividendPR Newswire
- Lilly (LLY) Reliance on International Sales: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Investors Pile Into Amgen in Search of Next Obesity Drug Payout [Yahoo! Finance]Yahoo! Finance
- 3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/3/24 - Form SD
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- LLY's page on the SEC website